Endo Pharmaceuticals Acquires Par Pharma

According to biospace.com, Endo Pharmaceuticals acquired Par Pharma for $8.05 billion. In the article, the CEO of Endo Pharmaceuticals says: “This transaction with Par builds upon our generics growth, adding a strong portfolio of high barrier-to-entry and attractive...

Q1 Productions Moves for the Kids

The Q1 Productions team raced around Chicago’s South Loop as a proud sponsor of the Lurie Children’s Hospital’s annual Move for the Kids 5k Run/Walk on Sunday, May 17, 2015. This was the third year that Q1 Productions participated in the race, and...

AZ Links with Abbott on Personalized Asthma Diagnostic

According to an article from PMLive.com, “AstraZeneca (AZ) has teamed up with Abbott to develop a companion diagnostic for experimental asthma drug tralokinumab, currently in phase III testing.  To date there are no approved companion diagnostics for asthma...

Patient Opinions on Devices Important to FDA

“New draft guidance from FDA gives industry more clarity on what patient perspective information can be considered for agency review, how best to collect this data, and how to incorporate the information into labeling” according to an article via...